chase irons retatrutide Chase Irons - Director at

It is important to ensure that patients provide truly informed consent and understand the terms of participation and that they require their own physicians prescription post-study if they are to continue receiving GLP-1 therapeutics

With semaglutide, over 85% of participants achieved 5% weight loss, and about a third lost 20% or more

Tirzepatide achieves similar sustained activity through its own molecular modifications

Common Skin Changes to Watch For Not everyone experiences all of these, but the most common changes include: Flatter cheeks or hollow temples from lost facial volume Loose or crepey skin along the jawline and neck A more tired or aged look around the eyes Softening skin on the arms and midsection after larger changes Knowing what to look for helps you get ahead of it rather than waiting until it bothers you

American College of Cardiology

Your doctor may need to adjust your GLP-1 dose, temporarily discontinue therapy, or investigate alternative causes for your symptoms